• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向肿瘤干细胞龛的困难。

The difficulty of targeting cancer stem cell niches.

机构信息

Life Science Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA.

出版信息

Clin Cancer Res. 2010 Jun 15;16(12):3121-9. doi: 10.1158/1078-0432.CCR-09-2933. Epub 2010 Jun 8.

DOI:10.1158/1078-0432.CCR-09-2933
PMID:20530700
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3182451/
Abstract

Normal stem cell niches typically are identified by their distinctive anatomical features and by association with tissue-specific stem cells. Identifying cancer stem cell (CSC) niches presents a special problem because there are few if any common anatomical features among tumors, and the physical phenotypes that reportedly describe the CSCs as entities may be subject to the host's microenvironment, sex, and tumor stage. Irrespective of a niche's location, the occupant's phenotype, or the precise molecular composition, all niches must do basically the same thing: maintain the activities in a stem cell that define it as such. Therefore, a potentially successful strategy, both for elaborating a molecular and cellular portrait of a CSC niche, and for therapeutically targeting them, is to identify components in the tumor microenvironment that are required for maintaining the functions of self-renewal, differentiation, and quiescence in the face of cytotoxic therapeutic regimens.

摘要

正常的干细胞龛通常通过其独特的解剖学特征和与组织特异性干细胞的关联来识别。鉴定癌症干细胞(CSC)龛位提出了一个特殊的问题,因为肿瘤之间几乎没有共同的解剖学特征,而且据报道描述 CSC 作为实体的物理表型可能受到宿主微环境、性别和肿瘤阶段的影响。无论龛位的位置、占据者的表型或确切的分子组成如何,所有龛位都必须基本做同样的事情:维持定义为干细胞的干细胞活动。因此,无论是详细阐述 CSC 龛位的分子和细胞特征,还是针对它们进行治疗,一个潜在的成功策略都是鉴定肿瘤微环境中的成分,这些成分对于维持自我更新、分化和在细胞毒性治疗方案中静止的功能是必需的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15b3/3182451/53eca64c32bc/nihms326524f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15b3/3182451/5081e139726b/nihms326524f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15b3/3182451/440631bb1b68/nihms326524f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15b3/3182451/90e52f07b8f4/nihms326524f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15b3/3182451/53eca64c32bc/nihms326524f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15b3/3182451/5081e139726b/nihms326524f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15b3/3182451/440631bb1b68/nihms326524f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15b3/3182451/90e52f07b8f4/nihms326524f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15b3/3182451/53eca64c32bc/nihms326524f4.jpg

相似文献

1
The difficulty of targeting cancer stem cell niches.靶向肿瘤干细胞龛的困难。
Clin Cancer Res. 2010 Jun 15;16(12):3121-9. doi: 10.1158/1078-0432.CCR-09-2933. Epub 2010 Jun 8.
2
The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells?癌症干细胞微环境:微环境在调节肿瘤细胞干性方面有多重要?
Cell Stem Cell. 2015 Mar 5;16(3):225-38. doi: 10.1016/j.stem.2015.02.015.
3
Characteristics of the cancer stem cell niche and therapeutic strategies.肿瘤干细胞生态位的特征和治疗策略。
Stem Cell Res Ther. 2022 Jun 3;13(1):233. doi: 10.1186/s13287-022-02904-1.
4
An alginate-based platform for cancer stem cell research.一种用于癌症干细胞研究的藻酸盐平台。
Acta Biomater. 2016 Jun;37:83-92. doi: 10.1016/j.actbio.2016.04.032. Epub 2016 Apr 19.
5
Cancer stem cells and angiogenesis.癌症干细胞与血管生成。
Int J Dev Biol. 2011;55(4-5):477-82. doi: 10.1387/ijdb.103225yz.
6
Cancer stem cells (CSCs) in cancer progression and therapy.癌症进展和治疗中的癌症干细胞 (CSCs)。
J Cell Physiol. 2019 Jun;234(6):8381-8395. doi: 10.1002/jcp.27740. Epub 2018 Nov 11.
7
Therapeutic approaches targeting cancer stem cells.针对癌症干细胞的治疗方法。
J Cancer Res Ther. 2018;14(7):1469-1475. doi: 10.4103/jcrt.JCRT_976_17.
8
Cancer stem cells niche: a target for novel cancer therapeutics.肿瘤干细胞龛:新型癌症治疗的靶点。
Cancer Treat Rev. 2013 May;39(3):290-6. doi: 10.1016/j.ctrv.2012.10.004. Epub 2012 Dec 5.
9
Cancer stem cells and niches: challenges in immunotherapy resistance.癌症干细胞与微环境:免疫治疗耐药性面临的挑战
Mol Cancer. 2025 Feb 25;24(1):52. doi: 10.1186/s12943-025-02265-2.
10
Cancer stem cell, niche and EGFR decide tumor development and treatment response: A bio-computational simulation study.癌症干细胞、生态位和 EGFR 决定肿瘤发展和治疗反应:一项生物计算模拟研究。
J Theor Biol. 2011 Jan 21;269(1):138-49. doi: 10.1016/j.jtbi.2010.10.016. Epub 2010 Oct 20.

引用本文的文献

1
Targeted Cancer Stem Cell Therapeutics: An Update.靶向癌症干细胞疗法:最新进展
Curr Top Med Chem. 2025;25(8):842-870. doi: 10.2174/0115680266275014240110071351.
2
Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies.探讨癌症干细胞与肿瘤微环境之间的动态相互作用:对新型治疗策略的启示。
J Transl Med. 2023 Oct 2;21(1):686. doi: 10.1186/s12967-023-04575-9.
3
Daunorubicin can eliminate iPS-derived cancer stem cells via ICAD/CAD-independent DNA fragmentation.

本文引用的文献

1
Cancer stem cells and self-renewal.癌症干细胞与自我更新。
Clin Cancer Res. 2010 Jun 15;16(12):3113-20. doi: 10.1158/1078-0432.CCR-09-2824. Epub 2010 Jun 8.
2
Targeting Hedgehog--a cancer stem cell pathway.靶向 Hedgehog——一种癌症干细胞通路。
Clin Cancer Res. 2010 Jun 15;16(12):3130-40. doi: 10.1158/1078-0432.CCR-09-2846. Epub 2010 Jun 8.
3
Targeting Wnt signaling: can we safely eradicate cancer stem cells?靶向 Wnt 信号:我们能否安全地根除癌症干细胞?
柔红霉素可通过不依赖ICAD/CAD的DNA片段化作用消除诱导多能干细胞衍生的癌症干细胞。
Cancer Drug Resist. 2019 Jun 19;2(2):335-350. doi: 10.20517/cdr.2019.01. eCollection 2019.
4
Genetic Clonality as the Hallmark Driving Evolution of Non-Small Cell Lung Cancer.基因克隆性作为驱动非小细胞肺癌进化的标志
Cancers (Basel). 2022 Apr 2;14(7):1813. doi: 10.3390/cancers14071813.
5
Nanoparticle-Based RNAi Therapeutics Targeting Cancer Stem Cells: Update and Prospective.基于纳米颗粒的RNA干扰疗法靶向癌症干细胞:最新进展与展望
Pharmaceutics. 2021 Dec 8;13(12):2116. doi: 10.3390/pharmaceutics13122116.
6
M2 macrophage microvesicle-inspired nanovehicles improve accessibility to cancer cells and cancer stem cells in tumors.M2 巨噬细胞微泡启发的纳米载体提高了肿瘤中癌细胞和肿瘤干细胞的可及性。
J Nanobiotechnology. 2021 Nov 27;19(1):397. doi: 10.1186/s12951-021-01143-5.
7
Cancer Stem Cells: Metabolic Characterization for Targeted Cancer Therapy.癌症干细胞:靶向癌症治疗的代谢特征
Front Oncol. 2021 Nov 5;11:756888. doi: 10.3389/fonc.2021.756888. eCollection 2021.
8
Targeting Cancer Stem Cell Markers or Pathways: A Potential Therapeutic Strategy for Oral Cancer Treatment.靶向癌症干细胞标志物或信号通路:口腔癌治疗的一种潜在治疗策略。
Int J Stem Cells. 2021 Nov 30;14(4):386-399. doi: 10.15283/ijsc21084.
9
Taking the road less traveled - the therapeutic potential of CBP/β-catenin antagonists.不走寻常路——CBP/β-连环蛋白拮抗剂的治疗潜力。
Expert Opin Ther Targets. 2021 Sep;25(9):701-719. doi: 10.1080/14728222.2021.1992386. Epub 2021 Oct 27.
10
Pharmacologically Targeting the WNT/β-Catenin Signaling Cascade: Avoiding the Sword of Damocles.靶向调控 WNT/β-联蛋白信号级联反应:避免达摩克利斯之剑。
Handb Exp Pharmacol. 2021;269:383-422. doi: 10.1007/164_2021_523.
Clin Cancer Res. 2010 Jun 15;16(12):3153-62. doi: 10.1158/1078-0432.CCR-09-2943. Epub 2010 Jun 8.
4
Targeting Notch to target cancer stem cells.针对 Notch 以靶向肿瘤干细胞。
Clin Cancer Res. 2010 Jun 15;16(12):3141-52. doi: 10.1158/1078-0432.CCR-09-2823. Epub 2010 Jun 8.
5
RNAi-mediated knockdown of Notch-1 leads to cell growth inhibition and enhanced chemosensitivity in human breast cancer.RNAi 介导的 Notch-1 敲低导致人乳腺癌细胞生长抑制和化疗敏感性增强。
Oncol Rep. 2010 Apr;23(4):893-9. doi: 10.3892/or_00000712.
6
Downregulation of Notch pathway by a gamma-secretase inhibitor attenuates AKT/mammalian target of rapamycin signaling and glucose uptake in an ERBB2 transgenic breast cancer model.γ-分泌酶抑制剂下调 Notch 通路可抑制 ERBB2 转基因乳腺癌模型中的 AKT/哺乳动物雷帕霉素靶蛋白信号通路和葡萄糖摄取。
Cancer Res. 2010 Mar 15;70(6):2476-84. doi: 10.1158/0008-5472.CAN-09-3114. Epub 2010 Mar 2.
7
Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival.Axl 是乳腺癌转移和患者生存的上皮-间充质转化诱导调节因子。
Proc Natl Acad Sci U S A. 2010 Jan 19;107(3):1124-9. doi: 10.1073/pnas.0909333107. Epub 2009 Dec 28.
8
Human mammary progenitor cell fate decisions are products of interactions with combinatorial microenvironments.人类乳腺祖细胞的命运决定是与组合微环境相互作用的产物。
Integr Biol (Camb). 2009 Jan;1(1):70-9. doi: 10.1039/b816472j. Epub 2008 Nov 12.
9
A luminal epithelial stem cell that is a cell of origin for prostate cancer.一种作为前列腺癌起源细胞的管腔上皮干细胞。
Nature. 2009 Sep 24;461(7263):495-500. doi: 10.1038/nature08361. Epub 2009 Sep 9.
10
Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers.异常管腔祖细胞作为BRCA1突变携带者基底肿瘤发生的候选靶细胞群。
Nat Med. 2009 Aug;15(8):907-13. doi: 10.1038/nm.2000. Epub 2009 Aug 2.